Patent · US Active

Stuffy nose deblocking composition having antiviral activity

US10660914B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

MARINOMED BIOTECH AG · AT

Inventors

Andreas Grassauer · Wien, AT
Eva Prieschl-Grassauer · Wien, AT
Angelika Bodenteich · Plesching, AT
Christiane Koller · Seyring, AT
Martina MOROKUTTI-KURZ · Wien, AT

Key dates

Filing date	Jul 12, 2016
Grant date	May 26, 2020
Priority date	—
Expiry date	Jul 12, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition has a stuffy nose deblocking activity. The composition includes a hyperosmolar aqueous solution of a non-ionic osmolality adjusting agent, optionally in combination with an ionic osmolality adjusting agent, wherein the composition further includes iota-carrageenan and/or kappa-carrageenan as an active antiviral ingredient in an antivirally effective amount, with the proviso that the composition in its ready-for-use formulation contains no more than 0-1.5% w/v of the ionic osmolality adjusting agent. The composition is useful for deblocking a stuffy nose and for prophylactic or therapeutic intervention of a number of viral infections of the upper respiratory tract.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.